Astrazeneca (AZN) Revenue (2009 - 2026)
Astrazeneca (AZN) reported Revenue of $15.38 billion for Q2 2026, up 6.4% from $14.46 billion a year earlier and up 0.6% from the prior quarter.
Astrazeneca (AZN) Revenue (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's Revenue came in at $61.37 billion, up 8.6% year-over-year; for FY2025, it came in at $58.74 billion, up 8.6% from FY2024.
- Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- By year, Revenue came in at $54.07 billion in FY2024 (+18.0%), $45.81 billion in FY2023 (+3.3%), $44.35 billion in FY2022 (+18.5%) and $37.42 billion in FY2021 (+40.6%).
- Five-year quarterly Revenue spans a low of $9.87 billion in Q3 2021 and a high of $15.5 billion in Q4 2025.
- Year over year, Revenue has now increased in each of the last 13 quarters, with growth averaging 12.0% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q4 2021 (growth of 62.1%); the low point was Q4 2022 (a decline of 6.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.29 billion (Q1 2026), $15.5 billion (Q4 2025) and $15.19 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vertex Pharmaceuticals | 133.09 Bn | 105.09 Bn | 2.84 Bn | 3.33 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.38 Bn |
| Mar 31, 2026 | 14.39 Bn |
| Dec 31, 2025 | 14.54 Bn |
| Sep 30, 2025 | 14.37 Bn |
| Jun 30, 2025 | 14.46 Bn |
| Mar 31, 2025 | 12.88 Bn |
| Dec 31, 2024 | 13.36 Bn |
| Sep 30, 2024 | 12.95 Bn |
| Jun 30, 2024 | 12.94 Bn |
| Mar 31, 2024 | 12.18 Bn |
| Dec 31, 2023 | 11.32 Bn |
| Sep 30, 2023 | 11.02 Bn |
| Jun 30, 2023 | 11.42 Bn |
| Mar 31, 2023 | 10.57 Bn |
| Dec 31, 2022 | 10.80 Bn |
| Sep 30, 2022 | 10.59 Bn |
| Jun 30, 2022 | 10.77 Bn |
| Mar 31, 2022 | 10.98 Bn |
| Dec 31, 2021 | 11.50 Bn |
| Sep 30, 2021 | 9.74 Bn |
Astrazeneca Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();